{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20210804",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "68298",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf",
              "date": "20210805",
              "type": "Label"
            },
            {
              "id": "68308",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/206143Orig1s008;209964Orig1s002ltr.pdf",
              "date": "20210830",
              "type": "Letter"
            },
            {
              "id": "68405",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf#page=24",
              "date": "20210818",
              "type": "Medication Guide"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20170110",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "46804",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206143Orig1s002lbl.pdf",
              "date": "20170111",
              "type": "Label"
            },
            {
              "id": "46856",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/206143Orig1s002ltr.pdf",
              "date": "20170119",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20150415",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "63926",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N206143_ivabradine_Orig_WR_11.pdf",
              "date": "19000101",
              "type": "Pediatric Written Request"
            },
            {
              "id": "63927",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/N206143_ivabradine_Amend_1.pdf",
              "date": "19000101",
              "type": "Pediatric Amendment 1"
            },
            {
              "id": "66842",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/402_209964 ivabradine clinical bpca.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "66843",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/401_209964 ivabradine CDTL bpca.pdf",
              "date": "19000101",
              "type": "Pediatric CDTL Review"
            },
            {
              "id": "66844",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/403_209964 ivabradine clinpharm bpca.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "66845",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/404_209964 ivabradine statistics bpca.pdf",
              "date": "19000101",
              "type": "Pediatric Statistical Review"
            },
            {
              "id": "10548",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206143Orig1s000ltr.pdf",
              "date": "20150416",
              "type": "Letter"
            },
            {
              "id": "19706",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206143Orig1s000lbl.pdf",
              "date": "20150416",
              "type": "Label"
            },
            {
              "id": "23013",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206143Orig1s000TOC.html",
              "date": "20151120",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20190513",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "58664",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206143s007lbl.pdf",
              "date": "20190513",
              "type": "Label"
            },
            {
              "id": "58729",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/206143Orig1s007ltr.pdf",
              "date": "20190515",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20160505",
          "review_priority": "PRIORITY",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        }
      ],
      "application_number": "NDA206143",
      "sponsor_name": "AMGEN INC",
      "openfda": {
        "application_number": [
          "NDA206143"
        ],
        "brand_name": [
          "CORLANOR"
        ],
        "generic_name": [
          "IVABRADINE"
        ],
        "manufacturer_name": [
          "Amgen Inc"
        ],
        "product_ndc": [
          "55513-800",
          "55513-810",
          "55513-813"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "IVABRADINE HYDROCHLORIDE"
        ],
        "rxcui": [
          "1649485",
          "1649491",
          "1649493",
          "1649495",
          "2168592",
          "2168596"
        ],
        "spl_id": [
          "8ab000cd-0258-489a-b1bb-4cc1ca359d6c"
        ],
        "spl_set_id": [
          "92018a65-38f6-45f7-91d4-a34921b81d0d"
        ],
        "package_ndc": [
          "55513-800-60",
          "55513-800-99",
          "55513-810-60",
          "55513-813-01",
          "55513-813-28"
        ],
        "unii": [
          "TP19837BZK"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "CORLANOR",
          "active_ingredients": [
            {
              "name": "IVABRADINE HYDROCHLORIDE",
              "strength": "EQ 5MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Discontinued",
          "te_code": "AB"
        },
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "CORLANOR",
          "active_ingredients": [
            {
              "name": "IVABRADINE HYDROCHLORIDE",
              "strength": "EQ 7.5MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Discontinued",
          "te_code": "AB"
        }
      ]
    }
  ]
}